UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000002897 |
|---|---|
| Receipt number | R000003534 |
| Scientific Title | Phase II Trial of Bevacizumab in Combination with XELOX in Colorectal Cancer Patients with Liver Metastases (H2, H3) |
| Date of disclosure of the study information | 2009/12/15 |
| Last modified on | 2019/02/03 21:25:17 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2009/12/15 03:40:46 | ||
| 2 | Update | 2012/10/10 14:33:16 | Publication of results |
|
| 3 | Update | 2012/10/24 10:31:29 | Post marketing survey by drug manufacture etc., specified by Japanese law. Email1 |
|
| 4 | Update | 2012/10/24 10:31:56 | Recruitment status |
|
| 5 | Update | 2013/12/15 10:13:37 | Recruitment status |
|
| 6 | Update | 2014/12/16 11:49:05 | Email |
|
| 7 | Update | 2019/02/03 21:25:17 | Recruitment status Publication of results |
